Relief Therapeutics Holding SA
SIX:RLF
Balance Sheet
Balance Sheet Decomposition
Relief Therapeutics Holding SA
Relief Therapeutics Holding SA
Balance Sheet
Relief Therapeutics Holding SA
| Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
15
|
11
|
14
|
5
|
2
|
2
|
0
|
1
|
4
|
0
|
0
|
0
|
0
|
0
|
38
|
45
|
19
|
15
|
15
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
15
|
11
|
14
|
5
|
2
|
2
|
0
|
1
|
4
|
0
|
0
|
0
|
0
|
0
|
38
|
45
|
19
|
15
|
15
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
6
|
1
|
1
|
0
|
0
|
0
|
6
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Accounts Receivables |
1
|
3
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
|
| Other Receivables |
0
|
4
|
1
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Current Assets |
0
|
0
|
6
|
4
|
7
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
9
|
8
|
1
|
1
|
2
|
|
| Total Current Assets |
16
|
17
|
22
|
9
|
9
|
2
|
1
|
10
|
9
|
0
|
1
|
0
|
0
|
0
|
47
|
55
|
23
|
18
|
20
|
|
| PP&E Net |
1
|
5
|
1
|
5
|
1
|
1
|
1
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
2
|
|
| PP&E Gross |
1
|
5
|
1
|
5
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
2
|
1
|
1
|
1
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Intangible Assets |
60
|
57
|
54
|
51
|
48
|
0
|
0
|
3
|
5
|
0
|
31
|
31
|
35
|
20
|
31
|
184
|
156
|
54
|
31
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
7
|
1
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
20
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
7
|
1
|
0
|
|
| Total Assets |
77
N/A
|
79
+3%
|
77
-3%
|
65
-15%
|
58
-11%
|
3
-94%
|
1
-61%
|
46
+3 469%
|
37
-21%
|
0
-100%
|
31
+241 615%
|
31
-1%
|
36
+15%
|
20
-44%
|
78
+293%
|
252
+222%
|
189
-25%
|
76
-60%
|
53
-30%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
2
|
1
|
1
|
8
|
4
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
2
|
|
| Accrued Liabilities |
8
|
3
|
3
|
3
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
3
|
3
|
3
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Current Liabilities |
2
|
8
|
4
|
5
|
3
|
0
|
0
|
4
|
3
|
0
|
0
|
1
|
1
|
1
|
4
|
14
|
5
|
2
|
3
|
|
| Total Current Liabilities |
10
|
11
|
7
|
8
|
5
|
3
|
4
|
19
|
11
|
0
|
2
|
2
|
2
|
3
|
7
|
20
|
11
|
7
|
5
|
|
| Long-Term Debt |
0
|
4
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
2
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
6
|
7
|
7
|
3
|
4
|
26
|
21
|
7
|
5
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
1
|
1
|
5
|
0
|
0
|
22
|
10
|
8
|
5
|
|
| Total Liabilities |
11
N/A
|
15
+38%
|
8
-47%
|
8
+10%
|
6
-30%
|
3
-53%
|
4
+41%
|
26
+551%
|
13
-48%
|
0
-100%
|
9
+13 820%
|
10
+9%
|
14
+43%
|
6
-61%
|
11
+98%
|
70
+537%
|
43
-38%
|
24
-44%
|
17
-31%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
4
|
6
|
7
|
19
|
20
|
21
|
21
|
32
|
44
|
56
|
56
|
1
|
|
| Retained Earnings |
66
|
64
|
68
|
56
|
52
|
0
|
3
|
16
|
17
|
7
|
3
|
1
|
0
|
7
|
35
|
67
|
115
|
213
|
230
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
208
|
216
|
214
|
265
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
12
|
6
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
66
N/A
|
65
-2%
|
69
+7%
|
57
-18%
|
52
-8%
|
0
-99%
|
3
N/A
|
20
N/A
|
23
+15%
|
0
N/A
|
22
N/A
|
21
-6%
|
21
+2%
|
14
-33%
|
67
+369%
|
182
+171%
|
145
-20%
|
52
-64%
|
37
-30%
|
|
| Total Liabilities & Equity |
77
N/A
|
79
+3%
|
77
-3%
|
65
-15%
|
58
-11%
|
3
-94%
|
1
-61%
|
46
+3 469%
|
37
-21%
|
0
-100%
|
31
+241 615%
|
31
-1%
|
36
+15%
|
20
-44%
|
78
+293%
|
252
+222%
|
189
-25%
|
76
-60%
|
53
-30%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
18
|
18
|
18
|
18
|
20
|
69
|
70
|
397
|
655
|
655
|
1 947
|
2 007
|
2 089
|
2 114
|
8
|
10
|
11
|
13
|
13
|
|